Dr. Thomas A. Hensing
Claim this profileNorthShore University HealthSystem-Glenbrook Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
10 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Thomas A. Hensing is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Thomas A. Hensing
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Thomas A. Hensing has experience with
- Durvalumab
- Biospecimen Collection
- Crizotinib
- Selpercatinib
- Pembrolizumab
- Pemetrexed Disodium
Breakdown of trials Thomas A. Hensing has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas A. Hensing specialize in?
Thomas A. Hensing focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Thomas A. Hensing currently recruiting for clinical trials?
Yes, Thomas A. Hensing is currently recruiting for 4 clinical trials in Glenview Illinois. If you're interested in participating, you should apply.
Are there any treatments that Thomas A. Hensing has studied deeply?
Yes, Thomas A. Hensing has studied treatments such as Durvalumab, Biospecimen Collection, Crizotinib.
What is the best way to schedule an appointment with Thomas A. Hensing?
Apply for one of the trials that Thomas A. Hensing is conducting.
What is the office address of Thomas A. Hensing?
The office of Thomas A. Hensing is located at: NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois 60026 United States. This is the address for their practice at the NorthShore University HealthSystem-Glenbrook Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.